Company intelligence / Profile preview

Corti

Copenhagen, Denmarkcorti.ai ↗

Ownership: Private
Development stage: Commercial

Overview

Corti has developed specialized AI foundation models purpose-built for healthcare, supporting clinicians with real-time documentation, patient assessment, and administrative automation. Their technology is used globally by emergency services and hospitals to improve accuracy of outcome predictions by up to 40% and reduce administrative workload by up to 90%. The company claims its models outperform general-purpose LLMs like GPT‑4 in speed, accuracy, conciseness, regulatory compliance, and multilingual support.

Modalities: Non-pharmacological therapy (AI-powered clinical decision support and documentation tools)
Industry: Digital Health Medical Devices

Partnerships

No major pharma/biotech partnerships disclosed; works directly with health systems/providers such as emergency services in Seattle/Boston/Sweden

Beyond the preview

Go deeper on Corti.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corti.

Explore the full profile